SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Dyadic International Inc – ‘10-K’ for 12/31/19 – ‘EX-101.SCH’

On:  Monday, 3/30/20, at 5:03pm ET   ·   For:  12/31/19   ·   Accession #:  1213809-20-18   ·   File #:  1-32513

Previous ‘10-K’:  ‘10-K’ on 3/27/19 for 12/31/18   ·   Next:  ‘10-K’ on 3/30/21 for 12/31/20   ·   Latest:  ‘10-K’ on 3/28/24 for 12/31/23   ·   1 Reference:  By:  Dyadic International Inc. – Latest ‘10-K’ on 3/28/24 for 12/31/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/30/20  Dyadic International Inc          10-K       12/31/19   61:7.5M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.04M 
 2: EX-4.2      Instrument Defining the Rights of Security Holders  HTML     33K 
 3: EX-10.11    Material Contract                                   HTML     16K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
41: R1          Document and Entity Information                     HTML     81K 
16: R2          Consolidated Balance Sheets                         HTML     94K 
30: R3          Consolidated Balance Sheets (Parenthetical)         HTML     41K 
54: R4          Consolidated Statements of Operations               HTML     58K 
43: R5          Consolidated Statements of Stockholders? Equity     HTML     53K 
17: R6          Consolidated Statements of Cash Flows               HTML     93K 
31: R7          Organization and Summary of Significant Accounting  HTML    129K 
                Policies                                                         
51: R8          Cash, Cash Equivalent, and Investments              HTML     95K 
46: R9          Research and Collaboration Agreements               HTML     40K 
26: R10         Income Taxes                                        HTML     80K 
22: R11         Commitments and Contingencies                       HTML     34K 
35: R12         Share-Based Compensation                            HTML     92K 
56: R13         Shareholders' Equity                                HTML     60K 
25: R14         Subsequent Events                                   HTML     27K 
21: R15         Organization and Summary of Significant Accounting  HTML    115K 
                Policies (Policies)                                              
34: R16         Organization and Summary of Significant Accounting  HTML     78K 
                Policies (Tables)                                                
55: R17         Cash, Cash Equivalent, and Investments (Tables)     HTML     93K 
28: R18         Income Taxes (Tables)                               HTML     80K 
20: R19         Commitments and Contingencies (Tables)              HTML     25K 
45: R20         Share-Based Compensation (Tables)                   HTML     86K 
52: R21         Shareholders' Equity (Tables)                       HTML     57K 
33: R22         Organization and Summary of Significant Accounting  HTML     70K 
                Policies - Textual (Details)                                     
15: R23         Organization and Summary of Significant Accounting  HTML     26K 
                Policies - Accounts Receivable (Details)                         
44: R24         Organization and Summary of Significant Accounting  HTML     32K 
                Policies - Prepaid Expenses and Other Current                    
                Assets (Details)                                                 
50: R25         Organization and Summary of Significant Accounting  HTML     29K 
                Policies - Accounts Payable (Details)                            
32: R26         Organization and Summary of Significant Accounting  HTML     29K 
                Policies - Accrued Expenses (Details)                            
14: R27         Organization and Summary of Significant Accounting  HTML     28K 
                Policies - Research and Development Costs                        
                (Details)                                                        
42: R28         Cash, Cash Equivalent, and Investments (Details)    HTML     58K 
53: R29         Research Collaboration and Sub-licensing            HTML     92K 
                Agreements (Details)                                             
58: R30         Income Taxes - Textual (Details)                    HTML     33K 
36: R31         Income Taxes - Components of Loss Before Income     HTML     26K 
                Taxes (Details)                                                  
18: R32         Income Taxes - (Benefit) Provision for Income Tax   HTML     29K 
                (Details)                                                        
23: R33         Income Taxes - Reconciliation Income Taxes          HTML     46K 
                (Details)                                                        
59: R34         Income Taxes - Deferred Income Tax Assets           HTML     38K 
                (Details)                                                        
37: R35         Commitments and Contingencies - Textual (Details)   HTML     44K 
19: R36         Commitments and Contingencies - Purchase            HTML     25K 
                Obligations (Details)                                            
24: R37         Share-Based Compensation - Textual (Details)        HTML     70K 
57: R38         Share-Based Compensation - Assumptions (Details)    HTML     41K 
38: R39         Share-Based Compensation - Stock Option Activity    HTML     66K 
                (Details)                                                        
47: R40         Share-Based Compensation - Stock Option Activity -  HTML     82K 
                Textual (Details)                                                
40: R41         Share-Based Compensation - Compensation Expense     HTML     27K 
                (Details)                                                        
13: R42         Shareholders' Equity - Textual (Details)            HTML     33K 
29: R43         Shareholders' Equity - Stock Repurchase (Details)   HTML     35K 
48: R44         Subsequent Events (Details)                         HTML     63K 
27: XML         IDEA XML File -- Filing Summary                      XML    102K 
39: XML         XBRL Instance -- dyai-20191231_htm                   XML   1.50M 
61: EXCEL       IDEA Workbook of Financial Reports                  XLSX     71K 
 9: EX-101.CAL  XBRL Calculations -- dyai-20191231_cal               XML    197K 
10: EX-101.DEF  XBRL Definitions -- dyai-20191231_def                XML    404K 
11: EX-101.LAB  XBRL Labels -- dyai-20191231_lab                     XML   1.30M 
12: EX-101.PRE  XBRL Presentations -- dyai-20191231_pre              XML    711K 
 8: EX-101.SCH  XBRL Schema -- dyai-20191231                         XSD    133K 
60: JSON        XBRL Instance as JSON Data -- MetaLinks              260±   396K 
49: ZIP         XBRL Zipped Folder -- 0001213809-20-000018-xbrl      Zip    342K

‘EX-101.SCH’   —   XBRL Schema — dyai-20191231

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- Copyright 2020 Workiva -->
<!-- r:62cd9607-c646-47d4-bb87-5f440e34d689,g:9aa84e3a-6ab2-4e1c-9b32-b3a92a5a8700 -->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dyai="http://www.dyadic.com/20191231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dyadic.com/20191231">
<xs:import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd"/>
<xs:import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd"/>
<xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
<xs:annotation>
<xs:appinfo>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dyai-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dyai-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dyai-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dyai-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="DocumentandEntityInformation" roleURI="http://www.dyadic.com/role/DocumentandEntityInformation">
<link:definition> 0001001 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.dyadic.com/role/CONSOLIDATEDBALANCESHEETS">
<link:definition> 1001002 - Statement - CONSOLIDATED BALANCE SHEETS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.dyadic.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
<link:definition> 1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.dyadic.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
<link:definition> 1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.dyadic.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
<link:definition> 1004005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.dyadic.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
<link:definition> 1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSummaryofSignificantAccountingPolicies" roleURI="http://www.dyadic.com/role/OrganizationandSummaryofSignificantAccountingPolicies">
<link:definition> 2101101 - Disclosure - Organization and Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.dyadic.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies">
<link:definition> 2202201 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.dyadic.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables">
<link:definition> 2303301 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesTextualDetails" roleURI="http://www.dyadic.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTextualDetails">
<link:definition> 2404401 - Disclosure - Organization and Summary of Significant Accounting Policies - Textual (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesAccountsReceivableDetails" roleURI="http://www.dyadic.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAccountsReceivableDetails">
<link:definition> 2405402 - Disclosure - Organization and Summary of Significant Accounting Policies - Accounts Receivable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.dyadic.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPrepaidExpensesandOtherCurrentAssetsDetails">
<link:definition> 2406403 - Disclosure - Organization and Summary of Significant Accounting Policies - Prepaid Expenses and Other Current Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesAccountsPayableDetails" roleURI="http://www.dyadic.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAccountsPayableDetails">
<link:definition> 2407404 - Disclosure - Organization and Summary of Significant Accounting Policies - Accounts Payable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesAccruedExpensesDetails" roleURI="http://www.dyadic.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAccruedExpensesDetails">
<link:definition> 2408405 - Disclosure - Organization and Summary of Significant Accounting Policies - Accrued Expenses (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentCostsDetails" roleURI="http://www.dyadic.com/role/OrganizationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentCostsDetails">
<link:definition> 2409406 - Disclosure - Organization and Summary of Significant Accounting Policies - Research and Development Costs (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashCashEquivalentandInvestments" roleURI="http://www.dyadic.com/role/CashCashEquivalentandInvestments">
<link:definition> 2110102 - Disclosure - Cash, Cash Equivalent, and Investments </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashCashEquivalentandInvestmentsTables" roleURI="http://www.dyadic.com/role/CashCashEquivalentandInvestmentsTables">
<link:definition> 2311302 - Disclosure - Cash, Cash Equivalent, and Investments (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashCashEquivalentandInvestmentsDetails" roleURI="http://www.dyadic.com/role/CashCashEquivalentandInvestmentsDetails">
<link:definition> 2412407 - Disclosure - Cash, Cash Equivalent, and Investments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashCashEquivalentandInvestmentsDetails_1" roleURI="http://www.dyadic.com/role/CashCashEquivalentandInvestmentsDetails_1">
<link:definition> 2412407 - Disclosure - Cash, Cash Equivalent, and Investments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ResearchandCollaborationAgreements" roleURI="http://www.dyadic.com/role/ResearchandCollaborationAgreements">
<link:definition> 2113103 - Disclosure - Research and Collaboration Agreements </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ResearchCollaborationandSublicensingAgreementsDetails" roleURI="http://www.dyadic.com/role/ResearchCollaborationandSublicensingAgreementsDetails">
<link:definition> 2414408 - Disclosure - Research Collaboration and Sub-licensing Agreements (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxes" roleURI="http://www.dyadic.com/role/IncomeTaxes">
<link:definition> 2115104 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesTables" roleURI="http://www.dyadic.com/role/IncomeTaxesTables">
<link:definition> 2316303 - Disclosure - Income Taxes (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesTextualDetails" roleURI="http://www.dyadic.com/role/IncomeTaxesTextualDetails">
<link:definition> 2417409 - Disclosure - Income Taxes - Textual (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesComponentsofLossBeforeIncomeTaxesDetails" roleURI="http://www.dyadic.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxesDetails">
<link:definition> 2418410 - Disclosure - Income Taxes - Components of Loss Before Income Taxes (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesBenefitProvisionforIncomeTaxDetails" roleURI="http://www.dyadic.com/role/IncomeTaxesBenefitProvisionforIncomeTaxDetails">
<link:definition> 2419411 - Disclosure - Income Taxes - (Benefit) Provision for Income Tax (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesReconciliationIncomeTaxesDetails" roleURI="http://www.dyadic.com/role/IncomeTaxesReconciliationIncomeTaxesDetails">
<link:definition> 2420412 - Disclosure - Income Taxes - Reconciliation Income Taxes (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesDeferredIncomeTaxAssetsDetails" roleURI="http://www.dyadic.com/role/IncomeTaxesDeferredIncomeTaxAssetsDetails">
<link:definition> 2421413 - Disclosure - Income Taxes - Deferred Income Tax Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsandContingencies" roleURI="http://www.dyadic.com/role/CommitmentsandContingencies">
<link:definition> 2122105 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.dyadic.com/role/CommitmentsandContingenciesTables">
<link:definition> 2323304 - Disclosure - Commitments and Contingencies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsandContingenciesTextualDetails" roleURI="http://www.dyadic.com/role/CommitmentsandContingenciesTextualDetails">
<link:definition> 2424414 - Disclosure - Commitments and Contingencies - Textual (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsandContingenciesPurchaseObligationsDetails" roleURI="http://www.dyadic.com/role/CommitmentsandContingenciesPurchaseObligationsDetails">
<link:definition> 2425415 - Disclosure - Commitments and Contingencies - Purchase Obligations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensation" roleURI="http://www.dyadic.com/role/ShareBasedCompensation">
<link:definition> 2126106 - Disclosure - Share-Based Compensation </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationTables" roleURI="http://www.dyadic.com/role/ShareBasedCompensationTables">
<link:definition> 2327305 - Disclosure - Share-Based Compensation (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationTextualDetails" roleURI="http://www.dyadic.com/role/ShareBasedCompensationTextualDetails">
<link:definition> 2428416 - Disclosure - Share-Based Compensation - Textual (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationAssumptionsDetails" roleURI="http://www.dyadic.com/role/ShareBasedCompensationAssumptionsDetails">
<link:definition> 2429417 - Disclosure - Share-Based Compensation - Assumptions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationStockOptionActivityDetails" roleURI="http://www.dyadic.com/role/ShareBasedCompensationStockOptionActivityDetails">
<link:definition> 2430418 - Disclosure - Share-Based Compensation - Stock Option Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationStockOptionActivityTextualDetails" roleURI="http://www.dyadic.com/role/ShareBasedCompensationStockOptionActivityTextualDetails">
<link:definition> 2431419 - Disclosure - Share-Based Compensation - Stock Option Activity - Textual (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareBasedCompensationCompensationExpenseDetails" roleURI="http://www.dyadic.com/role/ShareBasedCompensationCompensationExpenseDetails">
<link:definition> 2432420 - Disclosure - Share-Based Compensation - Compensation Expense (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareholdersEquity" roleURI="http://www.dyadic.com/role/ShareholdersEquity">
<link:definition> 2133107 - Disclosure - Shareholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareholdersEquityTables" roleURI="http://www.dyadic.com/role/ShareholdersEquityTables">
<link:definition> 2334306 - Disclosure - Shareholders' Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareholdersEquityTextualDetails" roleURI="http://www.dyadic.com/role/ShareholdersEquityTextualDetails">
<link:definition> 2435421 - Disclosure - Shareholders' Equity - Textual (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareholdersEquityStockRepurchaseDetails" roleURI="http://www.dyadic.com/role/ShareholdersEquityStockRepurchaseDetails">
<link:definition> 2436422 - Disclosure - Shareholders' Equity - Stock Repurchase (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SubsequentEvents" roleURI="http://www.dyadic.com/role/SubsequentEvents">
<link:definition> 2137108 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SubsequentEventsDetails" roleURI="http://www.dyadic.com/role/SubsequentEventsDetails">
<link:definition> 2438423 - Disclosure - Subsequent Events (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xs:appinfo>
</xs:annotation>
<xs:element id="dyai_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStock" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="dyai_ResearchandDevelopmentExpenseRelatedParty" abstract="false" name="ResearchandDevelopmentExpenseRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_DeferredTaxAssetLiabilityGross" abstract="false" name="DeferredTaxAssetLiabilityGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_CommitmentsRightToTerminateContractNoticePeriod" abstract="false" name="CommitmentsRightToTerminateContractNoticePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="dyai_DuPontDaniscoMember" abstract="true" name="DuPontDaniscoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_ConcentrationRiskNumberofCustomers" abstract="false" name="ConcentrationRiskNumberofCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="dyai_EffectiveIncomeTaxRateReconciliationTrueUpAdjustmentPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTrueUpAdjustmentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
<xs:element id="dyai_JupiterFloridaHeadquartersLeaseMember" abstract="true" name="JupiterFloridaHeadquartersLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_DebtSecuritiesHeldtomaturityFairValueCurrent" abstract="false" name="DebtSecuritiesHeldtomaturityFairValueCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_DebtSecuritiesHeldtomaturityAccumulatedUnrecognizedGainNoncurrent" abstract="false" name="DebtSecuritiesHeldtomaturityAccumulatedUnrecognizedGainNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_NovovetMember" abstract="true" name="NovovetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_ResearchAndDevelopmentInProcessCurrent" abstract="false" name="ResearchAndDevelopmentInProcessCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_CollaborativeArrangementPaymentforAdditionalDevelopmentandCommercialization" abstract="false" name="CollaborativeArrangementPaymentforAdditionalDevelopmentandCommercialization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_CommitmentDevelopmentPeriod" abstract="false" name="CommitmentDevelopmentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="dyai_VTTTechnicalResearchCentreofFinlandLtdMember" abstract="true" name="VTTTechnicalResearchCentreofFinlandLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
<xs:element id="dyai_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofBoardofDirectors" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofBoardofDirectors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="dyai_ContractResearchOrganizationsMember" abstract="true" name="ContractResearchOrganizationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_ServiceFrameworkAgreementMember" abstract="true" name="ServiceFrameworkAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_CollaborativeArrangementOptionToExtendExclusivityPeriod" abstract="false" name="CollaborativeArrangementOptionToExtendExclusivityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="dyai_ResearchAndDevelopmentExpenseContractedServicesRelatedParty" abstract="false" name="ResearchAndDevelopmentExpenseContractedServicesRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_SerumMember" abstract="true" name="SerumMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_IncomeTaxExpenseBenefitIncludingTrueUpAdjustment" abstract="false" name="IncomeTaxExpenseBenefitIncludingTrueUpAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_ResearchAndDevelopmentExpensePersonnelRelatedCosts" abstract="false" name="ResearchAndDevelopmentExpensePersonnelRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_CommitmentSuccessBonusAward" abstract="false" name="CommitmentSuccessBonusAward" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_ResearchServicesAgreementMember" abstract="true" name="ResearchServicesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_OperatingLeasesMonthlyRentalRate" abstract="false" name="OperatingLeasesMonthlyRentalRate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
<xs:element id="dyai_LeaseTypeAxis" abstract="true" name="LeaseTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
<xs:element id="dyai_PrepaidResearchandDevelopment" abstract="false" name="PrepaidResearchandDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_ResearchAndDevelopmentExpenseOutsideContractedServices" abstract="false" name="ResearchAndDevelopmentExpenseOutsideContractedServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_CollaborativeArrangementNumberofAntibodiesandVaccinesForDevelopmentAndCommercialization" abstract="false" name="CollaborativeArrangementNumberofAntibodiesandVaccinesForDevelopmentAndCommercialization" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="dyai_CommitmentToPayExpandedPeriod" abstract="false" name="CommitmentToPayExpandedPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="dyai_EmployeeMember" abstract="true" name="EmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_ResearchAndDevelopmentExpenseFacilitiesOverheadandOther" abstract="false" name="ResearchAndDevelopmentExpenseFacilitiesOverheadandOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodForfeited" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodForfeited" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="dyai_DebtSecuritiesHeldtomaturityFairValueNoncurrent" abstract="false" name="DebtSecuritiesHeldtomaturityFairValueNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_NonexecutiveEmployeesMember" abstract="true" name="NonexecutiveEmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_SharebasedCompensationAwardTrancheTwothroughFiveMember" abstract="true" name="SharebasedCompensationAwardTrancheTwothroughFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCash" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCash" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="dyai_IncreaseDecreaseinPrepaidResearchandDevelopment" abstract="false" name="IncreaseDecreaseinPrepaidResearchandDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_NetherlandsOfficeLeaseMember" abstract="true" name="NetherlandsOfficeLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_AccruedResearchandDevelopmentinProcessCurrent" abstract="false" name="AccruedResearchandDevelopmentinProcessCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_LeaseTypeDomain" abstract="true" name="LeaseTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_ResearchAndDevelopmentExpenseIncludingRelatedParty" abstract="false" name="ResearchAndDevelopmentExpenseIncludingRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_A2011PlanMember" abstract="true" name="A2011PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_CollaborativeArrangementMinimumObligationForResearchAndDevelopment" abstract="false" name="CollaborativeArrangementMinimumObligationForResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_DebtSecuritiesHeldtomaturityAccumulatedUnrecognizedLossNoncurrent" abstract="false" name="DebtSecuritiesHeldtomaturityAccumulatedUnrecognizedLossNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_CollaborativeArrangementEquityInterestAcquired" abstract="false" name="CollaborativeArrangementEquityInterestAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
<xs:element id="dyai_A2006PlanMember" abstract="true" name="A2006PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_PrepaidResearchandDevelopmentinProcessCurrent" abstract="false" name="PrepaidResearchandDevelopmentinProcessCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_DebtSecuritiesHeldtomaturityAccumulatedUnrecognizedGainCurrent" abstract="false" name="DebtSecuritiesHeldtomaturityAccumulatedUnrecognizedGainCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_CollaborativeArrangementDurationOfAgreement" abstract="false" name="CollaborativeArrangementDurationOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="dyai_TaxCutsandJobsActChangeInAlternativeMinimumTaxIncomeTaxBenefit" abstract="false" name="TaxCutsandJobsActChangeInAlternativeMinimumTaxIncomeTaxBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
<xs:element id="dyai_IndustrialTechnologyBusinessMember" abstract="true" name="IndustrialTechnologyBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_OperatingLeasesAnnualRentalRate" abstract="false" name="OperatingLeasesAnnualRentalRate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_CommitmentToPayExpanded" abstract="false" name="CommitmentToPayExpanded" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_NumberOfResearchOrganizationPerformingServiceUnderContract" abstract="false" name="NumberOfResearchOrganizationPerformingServiceUnderContract" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="dyai_DebtSecuritiesHeldtomaturityPremiumPaidonPurchase" abstract="false" name="DebtSecuritiesHeldtomaturityPremiumPaidonPurchase" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodNet" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodNet" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="dyai_CollaborativeArrangementExclusivityPeriod" abstract="false" name="CollaborativeArrangementExclusivityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="dyai_DebtSecuritiesHeldtomaturityAccumulatedUnrecognizedLossCurrent" abstract="false" name="DebtSecuritiesHeldtomaturityAccumulatedUnrecognizedLossCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_ConsultantMember" abstract="true" name="ConsultantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_CollaborativeArrangementMaximumObligationForResearchAndDevelopment" abstract="false" name="CollaborativeArrangementMaximumObligationForResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_ResearchAndDevelopmentExpenseAdditional" abstract="false" name="ResearchAndDevelopmentExpenseAdditional" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_AlphazymeMember" abstract="true" name="AlphazymeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_CollaborativeArrangementOptiontoObtainExclusiveCommercialSubLicenseForNumberofProteins" abstract="false" name="CollaborativeArrangementOptiontoObtainExclusiveCommercialSubLicenseForNumberofProteins" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="dyai_BDIHoldingsMember" abstract="true" name="BDIHoldingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_RevenueFromCollaborativeArrangementRecognized" abstract="false" name="RevenueFromCollaborativeArrangementRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_BDIMember" abstract="true" name="BDIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_ExecutivesandKeyPersonnelMember" abstract="true" name="ExecutivesandKeyPersonnelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_ScheduleofResearchandDevelopmentCostsTableTextBlock" abstract="false" name="ScheduleofResearchandDevelopmentCostsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
<xs:element id="dyai_CommitmentToPay" abstract="false" name="CommitmentToPay" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_CollaborativeArrangementResearchFundingMilestonePaymentsAndRoyaltiesPeriod" abstract="false" name="CollaborativeArrangementResearchFundingMilestonePaymentsAndRoyaltiesPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="dyai_VLPbioMember" abstract="true" name="VLPbioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_CollaborativeArrangementOutstandingCommitment" abstract="false" name="CollaborativeArrangementOutstandingCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_InvestmentsandCashAmortizedCost" abstract="false" name="InvestmentsandCashAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_CollaborativeArrangementOwnershipInterestConsiderationReceivableUponExtensionOfExclusivityPeriod" abstract="false" name="CollaborativeArrangementOwnershipInterestConsiderationReceivableUponExtensionOfExclusivityPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
<xs:element id="dyai_CollaborativeArrangementRevenueSharingPercentage" abstract="false" name="CollaborativeArrangementRevenueSharingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
<xs:element id="dyai_CollaborativeArrangementPaymentforResearchandDevelopmentAgreement" abstract="false" name="CollaborativeArrangementPaymentforResearchandDevelopmentAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="dyai_PubliclyAnnouncedRepurchasePlansMember" abstract="true" name="PubliclyAnnouncedRepurchasePlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_ContractorMember" abstract="true" name="ContractorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
<xs:element id="dyai_ResearchAndDevelopmentExpenseAdditionalTerm" abstract="false" name="ResearchAndDevelopmentExpenseAdditionalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
</xs:schema>

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/28/24  Dyadic International Inc.         10-K       12/31/23   64:6.6M                                   RDG Filings/FA
↑Top
Filing Submission 0001213809-20-000018   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., May 4, 4:19:38.1pm ET